Skip to main content
. 2017 Dec 28;33(2):277–283. doi: 10.3904/kjim.2016.195

Figure 2.

Figure 2.

Meta-analysis of the efficacy of tofacitinib (A) 5 mg and (B) 10 mg twice a day on number of patients withdrawn due to adverse events in rheumatoid arthritis. CI, confidence interval.